In cultured colon cancer cells, PPARδ inhibiteddifferentiation, conferred apoptotic resistance, and promoted cell migration [43], whereasprostacyclin, a metabolic product of COX-2 which modulates intestinaltumorigenesis [66], increased PPARδactivity [43]. This evidence concerns the gene PPARD and colonic neoplasm.